StockData
Rocket Pharmaceuticals, Inc. logo

Rocket Pharmaceuticals, Inc. (RCKT) stock

RCKTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 3/30
$1.95−0.16 (-7.58%)

Close on Nov 20, 2026Market cap $214.06MP/E –Yield –

Rocket Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Rocket Pharmaceuticals's pe ratio was 13.8× on Jan 31, 2018.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2018Jan 31, 201813.8×+6.2
2017Dec 29, 20177.6×–

More Rocket Pharmaceuticals figures

See a number that looks wrong?